ISRCTN ISRCTN27770434
DOI https://doi.org/10.1186/ISRCTN27770434
Secondary identifying numbers N/A
Submission date
23/03/2015
Registration date
21/04/2015
Last edited
24/01/2019
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Ear, Nose and Throat
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
There are plenty of studies that investigate how relief sounds for tinnitus sound therapy work for patients with hearing loss. The purpose of this study is to see how sounds can be used effectively with normal-hearing patients, using the Tinnitus Retraining Therapy (TRT) treatment approach.

Who can participate?
Normal-hearing patients with tinnitus symptoms can participate if they are between age 18-75.

What does the study involve?
The study involves the patient coming to a tinnitus clinic and being fit with a set of hearing aids that have a built-in sound generator (combination device). Patients will all follow the TRT fitting and treatment protocol and they will be asked to fill out questionnaires at a 3-month and a 6-month visit. Patients will be fit using non-traditional relief sounds and the results will be compared to patients who have been fitted with white noise relief sound.

What are the possible benefits and risks of participating?
The benefit is the elimination or reduction of tinnitus symptoms in patients with normal hearing. The risk may possibly be prolonged exposure to loud sounds. Patients will be counseled on the safe use of devices and how to avoid excessive noise exposure during the study. The risk is minimal.

Where is the study run from?
Fondazione Ascolta e Vivi (Italy).

When is the study starting and how long is it expected to run for?
From May to December 2015.

Who is funding the study?
Oticon A/S in Denmark and the Oticon filial in Italy.

Who is the main contact?
Luca Del Bo

Contact information

Prof Luca Del Bo
Scientific

Fondazione Ascolta e vivi
Del Bo Tecnologia per l'ascolto
Via Lanzone 36
Milano
20123
Italy

Study information

Study designInterventional single-centre study
Primary study designInterventional
Secondary study designNon randomised study
Study setting(s)Other
Study typeTreatment
Scientific titleNormal hearing tinnitus sound therapy: an interventional single-centre study
Study objectivesThe aim of this study is to investigate whether or not Tinnitus Retraining Therapy (TRT) using complex sounds such as red noise or pink noise or other sounds provided by the open ear hearing aids (Oticon Alta2 Pro Ti) can be equally or more effective in the rehabilitation of tinnitus than the classical white noise sound generator for a subgroup of patients with normal hearing up to at least 2 kHz.
Ethics approval(s)Fondazione Ascolta e vivi (FAEV) (Internal Scientific Board) – approval pending
Health condition(s) or problem(s) studiedNormal hearing persons with tinnitus symptoms
InterventionThe intervention is the type of tinnitus relief sound used in the treatment of tinnitus. In this study, the plan is to compare traditional white noise to non-traditional relief sounds (pink noise, red noise, nature sounds, modulated sounds). All sounds are integrated in a sound generator which is part of an Oticon Alta2 Pro Ti hearing aid.
Intervention typeDevice
Pharmaceutical study type(s)
Phase
Drug / device / biological / vaccine name(s)
Primary outcome measure1. Demonstrate that the Oticon device is at least as effective as other combination/sound generator devices that are used currently
2. Demonstrate that the Oticon device is more effective than other combination/sound generator devices that are used currently

In other words, to understand what makes the Ti different (better?) in comparison with other devices.
Secondary outcome measuresNew sounds: red or pink noise, modulated sounds, and/or ocean sounds are appreciated and preferred by patients
Overall study start date01/05/2015
Completion date01/12/2015

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
Upper age limit75 Years
SexBoth
Target number of participants20
Key inclusion criteria1. Normal hearing or hearing loss not more than 25 dB between 250 Hz and 2 kHz
2. Minimum 6 months tinnitus (no upper limit)
3. Category 1 (Jastreboff & Hazell, 2004) patients with normal hearing and severe tinnitus
4. Age 18-75 years
5. Inclusion of mono or bilateral tinnitus and with moderate hyperacusis (up to 6 in VAS scale), exclusion of pathological severe anxiety and depression (THI >= 80)
Key exclusion criteriaAll tinnitus aetiology excluding: Meniere, middle-external ear desease, somatosensory tinnitus under physical therapy
Date of first enrolment07/04/2015
Date of final enrolment01/08/2015

Locations

Countries of recruitment

  • Italy

Study participating centre

Fondazione Ascolta e Vivi
-
Italy

Sponsor information

Oticon A/S
Industry

Kongebakken 9
Smoerum
2765
Denmark

ROR logo "ROR" https://ror.org/05mwsq745

Funders

Funder type

Industry

Oticon A/S (Denmark)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot expected to be made available
Publication and dissemination planTo be confirmed at a later date
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/12/2017 24/01/2019 Yes No

Editorial Notes

24/01/2019: Publication reference added